ConductScience.org, home

Paper29907679

The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.

Antony J and 16 others. EMBO Rep, 2018. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer. Papers, record 29907679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29907679

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
PubMed
Journal
EMBO Rep
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.08
iCite
Revised in PubMed
2026-01-27
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Antony JJanehttps://orcid.org/0000-0002-2424-5470
2Zanini EElisahttps://orcid.org/0000-0002-5659-1626
3Kelly ZZoe
4Tan TZTuan Zeahttps://orcid.org/0000-0001-6624-1593
5Karali EEvdoxia
6Alomary MMohammad
7Jung YYoungrock
8Nixon KKatherine
9Cunnea PPaula
10Fotopoulou CChristina
11Paterson AAndrew
12Roy-Nawathe SSushmita
13Mills GBGordon B
14Huang RYRuby Yun-Ju
15Thiery JPJean Paulhttps://orcid.org/0000-0003-0478-5020
16Gabra HHanihttps://orcid.org/0000-0002-3322-4399
17Recchi CChiarahttps://orcid.org/0000-0003-1605-0945

Source PubMed

Download CSV of authors

Topics30

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Adhesion MoleculesMajor topic
Ovarian NeoplasmsMajor topic
Proto-Oncogene ProteinsMajor topic
Receptor Protein-Tyrosine KinasesMajor topic
Receptor-Like Protein Tyrosine Phosphatases, Class 5Major topic
Tumor Suppressor ProteinsMajor topic
Animals
Benzocycloheptenes
Cell Line, Tumor
Cell Movement
Cell Survival
Chickens
Cholesterol
Enzyme Activation
Epithelial Cells
Fallopian Tubes
Female
GPI-Linked Proteins
Gene Silencing
Humans
Intercellular Signaling Peptides and Proteins
MAP Kinase Signaling System
Membrane Microdomains
Neoplasm Invasiveness
Phosphorylation
Protein Binding
Treatment Outcome
Triazoles
Axl Receptor Tyrosine Kinase
Growth Arrest-Specific Protein 6

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Cancer Research UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in29967225Synergistic inactivation of AXL: a (cross)road to cure ovarian cancer?https://conductscience.org/library/papers/29967225

Source PubMed

Download CSV of comments and corrections

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123344542Regulatory networks defining EMT during cancer initiation and progression.Nat Rev Cancer2013https://conductscience.org/library/papers/23344542PubMed
222432005A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma.PLoS One2012https://conductscience.org/library/papers/22432005PubMed
320543576ERK2/Fra1/ZEB pathway induces epithelial-to-mesenchymal transition.Cell Cycle2010https://conductscience.org/library/papers/20543576PubMed
418770833Detecting protein-protein interactions with CFP-YFP FRET by acceptor photobleaching.Curr Protoc Cytom2006https://conductscience.org/library/papers/18770833PubMed
517041095Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.Mol Cancer Ther2006https://conductscience.org/library/papers/17041095PubMed
623666744Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.EMBO Mol Med2013https://conductscience.org/library/papers/23666744PubMed
723567973Gas6 induces cancer cell migration and epithelial-mesenchymal transition through upregulation of MAPK and Slug.Biochem Biophys Res Commun2013https://conductscience.org/library/papers/23567973PubMed
828401178Targeting the AXL signaling pathway in ovarian cancer.Mol Cell Oncol2017https://conductscience.org/library/papers/28401178PubMed
920959494Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.Cancer Res2010https://conductscience.org/library/papers/20959494PubMed
1012892714ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility.Cancer Cell2003https://conductscience.org/library/papers/12892714PubMed
1125568918The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.Nat Rev Cancer2014https://conductscience.org/library/papers/25568918PubMed
1218539112Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.Dev Cell2008https://conductscience.org/library/papers/18539112PubMed
1327703030The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.Sci Signal2016https://conductscience.org/library/papers/27703030PubMed
1416407160Phase coexistence and connectivity in the apical membrane of polarized epithelial cells.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16407160PubMed
1520393554International network of cancer genome projects.Nature2010https://conductscience.org/library/papers/20393554PubMed
1618714356OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.PLoS One2008https://conductscience.org/library/papers/18714356PubMed
1724026012Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.Mol Cancer Ther2013https://conductscience.org/library/papers/24026012PubMed
1817550342Function of the zinc-finger transcription factor SNAI2 in cancer and development.Annu Rev Genet2007https://conductscience.org/library/papers/17550342PubMed
1922841668Tumor grafts derived from sarcoma patients retain tumor morphology, viability, and invasion potential and indicate disease outcomes in the chick chorioallantoic membrane model.Cancer Lett2012https://conductscience.org/library/papers/22841668PubMed
206766487Evaluation of the polyene antibiotic filipin as a cytochemical probe for membrane cholesterol.J Histochem Cytochem1980https://conductscience.org/library/papers/6766487PubMed

See all 59 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
41991507Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistance.Signal Transduct Target Ther2026https://conductscience.org/library/papers/41991507PubMed
41762656Lipocalin 2 orchestrates resistance to ferroptosis via AXL.Cell Rep2026https://conductscience.org/library/papers/41762656PubMed
41561740Downregulation of OPCML is associated with activation of AKT signaling and aggressive phenotypes in glioblastoma cells.Front Oncol2025https://conductscience.org/library/papers/41561740PubMed
40699804Bioinformatic RNA-Seq Functional Profiling of the Tumor Suppressor Gene OPCML in Ovarian Cancers: The Multifunctional, Pleiotropic Impacts of Having Three Ig Domains.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699804PubMed
38474160Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.Int J Mol Sci2024https://conductscience.org/library/papers/38474160PubMed
36193770Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.Thorac Cancer2022https://conductscience.org/library/papers/36193770PubMed
35582229Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade.Cancer Drug Resist2020https://conductscience.org/library/papers/35582229PubMed
35572601Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition.Front Immunol2022https://conductscience.org/library/papers/35572601PubMed
35478117Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma.In Vivo2022https://conductscience.org/library/papers/35478117PubMed
35433461Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC).Front Oncol2022https://conductscience.org/library/papers/35433461PubMed
35071225The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer.Front Cell Dev Biol2021https://conductscience.org/library/papers/35071225PubMed
34697068OPCML Exerts Antitumor Effects in Cholangiocarcinoma via AXL/STAT3 Inactivation and Rho GTPase Down-regulation.Cancer Genomics Proteomics2021https://conductscience.org/library/papers/34697068PubMed
34576116Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/34576116PubMed
34277602NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway.Front Cell Dev Biol2021https://conductscience.org/library/papers/34277602PubMed
33780951Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.Cells Tissues Organs2022https://conductscience.org/library/papers/33780951PubMed
32895125[Luteolin reverses OPCML methylation to inhibit proliferation of breast cancer MDA-MB-231 cells].Nan Fang Yi Ke Da Xue Xue Bao2020https://conductscience.org/library/papers/32895125PubMed
32595215Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.Cancer Gene Ther2021https://conductscience.org/library/papers/32595215PubMed
32298237Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis.Aging (Albany NY)2020https://conductscience.org/library/papers/32298237PubMed
31969654Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival.Sci Rep2020https://conductscience.org/library/papers/31969654PubMed
31959629Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.J Biol Chem2020https://conductscience.org/library/papers/31959629PubMed

See all 25 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29907679

GET https://conductscience.org/api/papers/v1/29907679/references?page=2